Ignite Creation Date:
2025-12-24 @ 12:44 PM
Ignite Modification Date:
2026-04-20 @ 9:07 AM
Study NCT ID:
NCT02128061
Status:
COMPLETED
Last Update Posted:
2021-04-13
First Post:
2014-04-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+
Sponsor:
The Lymphoma Academic Research Organisation
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SENIOR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |